Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) Director Nitin Kaushal sold 8,852 shares of the stock in a transaction that occurred on Thursday, June 26th. The stock was sold at an average price of $7.00, for a total transaction of $61,964.00. Following the transaction, the director owned 126,843 shares in the company, valued at approximately $887,901. The trade was a 6.52% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Nitin Kaushal also recently made the following trade(s):
- On Friday, June 27th, Nitin Kaushal sold 34,100 shares of Viemed Healthcare stock. The shares were sold at an average price of $7.01, for a total transaction of $239,041.00.
Viemed Healthcare Price Performance
Shares of NASDAQ VMD traded up $0.09 during mid-day trading on Thursday, reaching $7.17. The company had a trading volume of 96,426 shares, compared to its average volume of 144,576. The firm has a market cap of $283.16 million, a price-to-earnings ratio of 23.88 and a beta of 1.37. The business's 50-day simple moving average is $6.80 and its 200 day simple moving average is $7.37. Viemed Healthcare, Inc. has a one year low of $6.14 and a one year high of $9.81. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.26 and a current ratio of 1.38.
Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.06 earnings per share for the quarter, meeting analysts' consensus estimates of $0.06. Viemed Healthcare had a return on equity of 9.49% and a net margin of 5.28%. The firm had revenue of $59.10 million for the quarter, compared to the consensus estimate of $60.60 million.
Institutional Trading of Viemed Healthcare
Several large investors have recently bought and sold shares of the business. Corton Capital Inc. acquired a new position in Viemed Healthcare during the fourth quarter worth about $82,000. AQR Capital Management LLC bought a new stake in shares of Viemed Healthcare during the 1st quarter valued at approximately $90,000. EntryPoint Capital LLC acquired a new position in Viemed Healthcare during the 4th quarter worth approximately $92,000. Prudential Financial Inc. bought a new position in Viemed Healthcare in the 4th quarter valued at approximately $93,000. Finally, Man Group plc acquired a new stake in Viemed Healthcare in the fourth quarter valued at approximately $95,000. 74.24% of the stock is owned by institutional investors and hedge funds.
About Viemed Healthcare
(
Get Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Recommended Stories
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
